Skip to main content

Written question asked by Chris Green (Conservative) on Tuesday, 12 February 2019, in the House of Commons. It was due for an answer on Thursday, 14 February 2019. It was answered by Steve Brine (Conservative) on Wednesday, 20 February 2019 on behalf of the Department of Health and Social Care.


Life Sciences: Technology

Question

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of charging for technology appraisals and highly specialised technology recommendations on the medical technology and wider life sciences sector.

Answer

The introduction of charges is intended to create a sustainable funding model for the National Institute for Health and Care Excellence’s (NICE) technology appraisal and highly specialised technologies programmes that better positions it to adapt to future changes in the life sciences sector. The Government carried out a public consultation on the introduction of charges and took full account of the comments received in deciding to proceed. The Government response to the consultation and the Impact Assessment, published alongside the regulations, assess the impact of the introduction of charging on all relevant stakeholders, including the life sciences industry and NICE. As explained in the Government response and Impact Assessment, small companies whose products are undergoing assessment will benefit from a 75% discount, which is intended to minimise barriers to the participation of small companies. The Government response is available at the following link:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/762725/government-response-to-nice-recommendations-consultation.pdf

The Impact Assessment at is available at the following link:

http://www.legislation.gov.uk/ukia/2018/171/pdfs/ukia_20180171_en.pdf


Secondary information

Type
Written question
Reference
220262
Session
2017-19
Grouped for answer
Yes
Subjects
Medical equipment National Institute for Health and Care Excellence Technology Life sciences
Link
View this Written question on www.parliament.uk